A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...

After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Proton therapy is an advanced radiation treatment that precisely targets tumors with a goal of limiting harm to healthy tissue. It may help reduce short- and long-term side effects, lower the risk of ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...

It may come as no surprise that breast cancer is the most common cancer in women worldwide. In the United States, about 275,000 women are diagnosed with breast cancer each year. Triple-negative breast ...

Fred Hutch board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors ...